US Broker Ratings

Charles River Laboratories Inte (CRL) Stock Analysis: Evaluating Growth Amidst Mixed Financial Metrics

Charles River Laboratories International, Inc. (NYSE: CRL), a key player in the healthcare sector, particularly within the diagnostics and research industry, is capturing investor attention with..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a 42.89% Potential Upside in Healthcare Tech

Investors are keenly eyeing Waystar Holding Corp. (NASDAQ: WAY), as the company is positioned for noteworthy growth within the healthcare technology sector. With a current market..

STERIS plc (STE) Stock Analysis: Strong Buy Ratings and 17.72% Upside Potential

For investors seeking a robust opportunity in the healthcare sector, STERIS plc (STE) stands out with compelling growth prospects and analyst confidence. This Ireland-based medical devices..

Revvity, Inc. (RVTY) Stock Analysis: Navigating Healthcare Innovation with Modest Growth Potential

Revvity, Inc. (RVTY), a stalwart in the healthcare sector, operates within the diagnostics and research industry, providing indispensable health sciences solutions. Headquartered in Waltham, Massachusetts, Revvity’s..

Waters Corporation (WAT) Stock Analysis: Unlocking a 6% Upside Potential in the Healthcare Sector

Waters Corporation (NYSE: WAT) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $37.24..

Repligen Corporation (RGEN) Stock Analysis: A 23.67% Upside Potential Amid Strong Buy Ratings

Repligen Corporation (NASDAQ: RGEN), a key player in the healthcare sector specializing in medical instruments and supplies, is drawing significant attention from investors, thanks to its..

GSK plc (GSK) Stock Analysis: Understanding the 5.54% Upside in a Resilient Healthcare Giant

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, presents an intriguing opportunity for investors seeking stability with a touch of growth potential. With a..

BeOne Medicines Ltd. (ONC) Stock Analysis: Uncovering a 38.55% Potential Upside in the Biotech Sector

BeOne Medicines Ltd. (ONC), a Swiss-based biotechnology titan, is capturing investor attention with its impressive market cap of $30.88 billion and a potential upside of 38.55%...

Avantor, Inc. (AVTR) Stock Analysis: Navigating a Healthcare Giant with a $7.05 Billion Market Cap

Avantor, Inc. (AVTR), a stalwart in the healthcare sector, operates within the medical instruments and supplies industry. The company, headquartered in Radnor, Pennsylvania, boasts a substantial..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating Growth in the Medical Devices Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors seeking exposure..

Cardinal Health, Inc. (CAH) Stock Analysis: Stellar Revenue Growth and Analyst Enthusiasm Propel Market Sentiment

Cardinal Health, Inc. (NYSE: CAH), a titan in the healthcare sector, remains a compelling prospect for investors, thanks to its robust revenue growth and favorable analyst..

Penumbra, Inc. (PEN) Stock Analysis: A Healthcare Innovator with a 14.40% Potential Upside

Investors with an eye on the healthcare sector might find Penumbra, Inc. (NYSE: PEN) an intriguing option, as the medical device company currently exhibits a notable..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating a 19.90% Potential Upside with Strategic Health Tech Innovations

Koninklijke Philips N.V. (NYSE: PHG), a stalwart in the healthcare sector, is poised for intriguing movement as it sits at the intersection of innovation and financial..

ResMed Inc. (RMD) Stock Analysis: A 24% Upside Potential with Robust Revenue Growth

ResMed Inc. (NYSE: RMD), a key player in the healthcare sector, has been making waves with its innovative solutions in the medical instruments and supplies industry...

Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Powerhouse with Strong Revenue Growth and High Analyst Interest

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, continues to capture investor attention with its robust performance metrics and strategic positioning in oncology...

Bristol-Myers Squibb (BMY) Stock Analysis: A Steady Dividend Yield with a Strategic Edge

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to capture investor attention with its robust presence in the biopharmaceutical industry. With a..

Stryker Corporation (SYK) Stock Analysis: Exploring an 18.45% Potential Upside in the Medical Devices Sector

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector specializing in medical devices, is captivating investor attention with its robust market position and promising potential..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating Revenue Challenges and Valuation Metrics

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) stands as a prominent player in the global pharmaceutical landscape, headquartered in Hyderabad, India. Operating within the healthcare sector, the..

AptarGroup, Inc. (ATR) Investor Outlook: Unpacking the 26% Potential Upside for Healthcare Investors

AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector, is drawing attention with a noteworthy potential upside of 26.34%. Known for its innovative drug..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating the Potential 12.84% Upside in the Healthcare Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) has established itself as a stalwart in the medical devices industry, offering a diverse range of orthopedic reconstructive products and..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds